Valuation: Arcoma AB

Market Cap 122M 12.19M 10.98M 10.15M 9.17M 17.36M 1.14B 17.79M 48.48M 612M 45.74M 44.77M 1.95B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 86.4M 8.66M 7.8M 7.21M 6.52M 12.33M 812M 12.63M 34.43M 435M 32.49M 31.8M 1.38B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.73%
Yield 2024 *
-
Yield 2025 -
1 week+6.25%
Current month+6.52%
1 month+12.43%
3 months-4.06%
6 months+4.68%
Current year+15.80%
1 week 8.24
Extreme 8.24
8.68
1 month 7
Extreme 7
8.78
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
10.05
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
18.3
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 01/01/2023
Director of Finance/CFO - 15/08/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Chairman 54 01/01/2017
Director/Board Member 59 01/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+6.25%+13.33%+8.97% 12.29M
-0.07%+1.64%+22.37%+60.05% 266B
-0.34%+0.16%+9.05%+19.45% 166B
-0.11%-6.76%-21.43%+62.00% 156B
+0.96%-1.51%-55.97%-12.47% 64.79B
+1.73%+6.48%+24.25%+64.79% 59.81B
+1.35%-2.97%-2.05%-8.59% 53.3B
-0.52%-0.12%+18.42%+63.13% 50.15B
-0.26%-1.89%+1.90%+84.62% 49.47B
-0.97%+0.71%+21.95%+84.00% 46.72B
Average +0.17%-0.24%+3.18%+42.60% 91B
Weighted average by Cap. +0.05%-0.39%+4.24%+46.87%

Financials

2024 2025
Net sales 157M 15.71M 14.16M 13.08M 11.83M 22.38M 1.47B 22.93M 62.5M 789M 58.97M 57.72M 2.51B 131M 13.11M 11.81M 10.91M 9.87M 18.67M 1.23B 19.13M 52.13M 658M 49.19M 48.14M 2.1B
Net income 11.18M 1.12M 1.01M 933K 843K 1.6M 105M 1.63M 4.46M 56.27M 4.2M 4.11M 179M 5.03M 504K 454K 420K 379K 718K 47.27M 736K 2M 25.32M 1.89M 1.85M 80.57M
Net Debt -13.32M -1.33M -1.2M -1.11M -1M -1.9M -125M -1.95M -5.31M -67.03M -5.01M -4.9M -213M -35.23M -3.53M -3.18M -2.94M -2.66M -5.03M -331M -5.15M -14.04M -177M -13.25M -12.97M -564M
Projected Income Statement - Annual - Arcoma AB
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
10/11/26 SEK 8.500 0.00% 37,350
09/11/26 SEK 8.500 0.00% 6,176
05/11/26 SEK 8.500 +6.25% 16,229
04/11/26 SEK 8.000 -6.76% 500
03/11/26 SEK 8.580 -2.28% 10
  1. Stock Market
  2. Stocks
  3. ARCOMA Stock